Skip to contentSkip to filters

We use cookies for analytics.

Grant, Call number PAR-25-184

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

National Institutes of Health

Related content

About

This phased award supports early clinical trials of drugs or neuromodulation devices for mental disorders. Teams study target engagement and clinical response, with an initial R61 phase and a possible transition to R33 support.

Topics

Eligibility

Covers: The announcement provides phased R61/R33 research support.

Eligible organizations based outside the US may apply.

simpler.grants.govgrants.nih.gov

Eligible organizations include universities, nonprofit research organizations and other categories specified in the announcement. Eligible organizations based outside the US may apply.

Source: simpler.grants.gov